Literature DB >> 31656757

Telemedicine for infectious disease care-how do we measure the true value?

Ramya Sita Palacholla1,2, Joseph C Kvedar1,2.   

Abstract

Year:  2019        PMID： 31656757      PMCID： PMC6789328          DOI： 10.21037/atm.2019.07.81

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

1.  The use and interpretation of quasi-experimental studies in infectious diseases.

Authors:  Anthony D Harris; Douglas D Bradham; Mona Baumgarten; Ilene H Zuckerman; Jeffrey C Fink; Eli N Perencevich
Journal:  Clin Infect Dis       Date:  2004-05-12       Impact factor: 9.079

Review 2.  Use of telemedicine technologies in the management of infectious diseases: a review.

Authors:  Parmvir Parmar; David Mackie; Sunil Varghese; Curtis Cooper
Journal:  Clin Infect Dis       Date:  2014-12-16       Impact factor: 9.079

3.  Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases.

Authors:  Jeremy D Young; Rima Abdel-Massih; Thomas Herchline; Lewis McCurdy; Kay J Moyer; John D Scott; Brian R Wood; Javeed Siddiqui
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

4.  Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits.

Authors:  Maroula Vasilopoulou; Andriana I Papaioannou; Georgios Kaltsakas; Zafeiris Louvaris; Nikolaos Chynkiamis; Stavroula Spetsioti; Eleni Kortianou; Sofia Antiopi Genimata; Anastasios Palamidas; Konstantinos Kostikas; Nikolaos G Koulouris; Ioannis Vogiatzis
Journal:  Eur Respir J       Date:  2017-05-25       Impact factor: 16.671

5.  Treating acute infections by telemedicine in the home.

Authors:  Lawrence Eron; Paula King; Michelle Marineau; Cyndee Yonehara
Journal:  Clin Infect Dis       Date:  2004-09-14       Impact factor: 9.079

6.  A brief retrospective review of medical records comparing outcomes for inpatients treated via telehealth versus in-person protocols: is telehealth equally effective as in-person visits for treating neutropenic fever, bacterial pneumonia, and infected bacterial wounds?

Authors:  Aristides Assimacopoulos; Rabiul Alam; Manuel Arbo; Jawad Nazir; Ding-Geng Chen; Susan Weaver; Marilyn Dahler-Penticoff; Karla Knobloch; Mary DeVany; Cheryl Ageton
Journal:  Telemed J E Health       Date:  2008-10       Impact factor: 3.536

7.  Telemedicine and Infectious Diseases Practice: A Leap Forward or a Step Back?

Authors:  Rima C Abdel-Massih; John W Mellors
Journal:  Open Forum Infect Dis       Date:  2019-04-20       Impact factor: 3.835

8.  Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.

Authors:  Thomas Ringbæk; Allan Green; Lars Christian Laursen; Ejvind Frausing; Eva Brøndum; Charlotte Suppli Ulrik
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-03

9.  Telecare for diabetes, CHF or COPD: effect on quality of life, hospital use and costs. A randomised controlled trial and qualitative evaluation.

Authors:  Timothy W Kenealy; Matthew J G Parsons; A Paul B Rouse; Robert N Doughty; Nicolette F Sheridan; Jennifer K Harré Hindmarsh; Sarah C Masson; Harry H Rea
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.